ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,442, issued on Oct. 6, was assigned to UNM RAINFOREST INNOVATIONS (Albuquerque, N.M.) and TEXAS A & M UNIVERSITY SYSTEMS (College Station, Texas).

"Signature miRNA to predict neonatal opioid withdrawal syndrome (NOWS)" was invented by Amanda Mahnke (Bryan, Texas), Rajesh Miranda (Bryan, Texas) and Ludmila Bakhireva (Los Ranchos, N.M.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the discovery of miRNAs which can be isolated from the blood of neonates, especially the umbilical cord and/or placental blood of neonates which have been determined to be biomarkers for neonatal opioid withdrawal syndrome (NOWS). One or more...